Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2023 - 01 - 09 symbols : SNY save search
Anti-inflammatory therapeutics market size to increase by USD 39.32 billion; North America to contribute 45% of market growth - Technavio
Published: 2023-01-09 (Crawled : 00:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -0.52%
H: 1.79%
C: 1.73%
NVS | $93.815 1.35% 410K
|
Health Technology
|
| O: 0.31%
H: 0.66%
C: 0.23%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: 0.58%
H: 0.39%
C: 0.03%
ABBV | News | $164.91 0.15% 1.2M
|
Health Technology
|
| O: 0.35%
H: 0.12%
C: -1.6%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
AMGN | $265.32 0.98% 550K
|
Health Technology
|
| O: 0.68%
H: 0.98%
C: 0.71%
america therapeutics growth market
TFF Pharmaceuticals Announces the Appointment of Zamaneh Mikhak, M.D. as Chief Medical Officer
Published: 2023-01-09 (Crawled : 19:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
TFFP | $3.135 640
|
Health Technology
|
| O: 2.86%
H: 3.7%
C: 1.85%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
pharmaceuticals medical
Antibiotics market to grow by 5.11% Y-O-Y from 2022 to 2023: Rising prevalence of infectious diseases will drive growth - Technavio
Published: 2023-01-09 (Crawled : 19:00) - prnewswire.com
ALPMF | $9.17 16K
|
Health Technology
|
| O: -1.98%
H: 0.0%
C: 0.0%
GLAXF | $20.2 510
|
Health Technology
|
| O: -0.52%
H: 1.79%
C: 1.73%
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -1.78%
H: 0.14%
C: 0.07%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: 0.58%
H: 0.39%
C: 0.03%
ABBV | News | $164.91 0.15% 1.2M
|
Health Technology
|
| O: 0.35%
H: 0.12%
C: -1.6%
ABT | News | $107.24 1.87% 2M
|
Health Technology
|
| O: 0.31%
H: 1.4%
C: 1.2%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
antibiotics growth market
Innovent Announces First Participant Dosed in a Phase 3 Clinical Study (DREAMS-1) of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes
Published: 2023-01-09 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
LLY | $731.1 -1.99% 1M
|
Health Technology
|
| O: 0.29%
H: 0.27%
C: -3.89%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
INCY | $52.6 -0.42% 380K
|
Health Technology
|
| O: 0.02%
H: 0.36%
C: -2.56%
ibi362 chinese diabetes study
DiNAQOR Appoints Two Seasoned Executives to Leadership Team
Published: 2023-01-09 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
Rheumatoid Arthritis Market is Expected to Showcase Significant Growth in the 7MM at a Minimal CAGR of 1.9% During the Study Period (2019-2032), Predicts DelveInsight
Published: 2023-01-09 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
LLY | $731.1 -1.99% 1M
|
Health Technology
|
| O: 0.29%
H: 0.27%
C: -3.89%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
INCY | $52.6 -0.42% 380K
|
Health Technology
|
| O: 0.02%
H: 0.36%
C: -2.56%
expected growth study market
CureVac Appoints Alexander Zehnder as CEO From April 1, 2023
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
CVAC | News | $2.42 -0.82% 81K
|
Health Technology
|
| O: 22.46%
H: 10.13%
C: 2.42%
ceo
ReCode Therapeutics Announces Strategic Collaboration with AskBio to Explore Single Vector Gene-Editing Platform
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
collaboration therapeutics platform
Nurix Therapeutics Advances Promising Targeted Protein Modulation Pipeline and Outlines 2023 Strategic Priorities
Published: 2023-01-09 (Crawled : 14:00) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
NRIX 2 d | $14.215 -1.56% 110K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: -8.06%
therapeutics
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
Published: 2023-01-09 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
IGMS | $7.24 -2.29% 47K
|
Health Technology
|
| O: 10.09%
H: 1.73%
C: -1.29%
igm-8444 trial update phase 1
Foundational RNA and cLNP expert Antonin (Tony) de Fougerolles joins Etherna as independent board member
Published: 2023-01-09 (Crawled : 12:20) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
CureVac ernennt Alexander Zehnder zum Vorstandsvorsitzenden ab 1. April 2023
Published: 2023-01-09 (Crawled : 12:00) - curevac.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: -1.81%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: 0.11%
H: 0.69%
C: -1.23%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
CVAC | News | $2.42 -0.82% 81K
|
Health Technology
|
| O: 22.46%
H: 10.13%
C: 2.42%
2022 Corporate Reputation of Pharma Companies Report: Patient Perspective of 520 Cancer Patient Groups During 2021
Published: 2023-01-09 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
pharma companies cancer
Immune Checkpoint Inhibitors Market Predicted to Reach USD 155.1 Billion, Globally, by 2031 at 16.1% CAGR: Allied Market Research
Published: 2023-01-09 (Crawled : 10:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: -1.81%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
AZNCF | $138.24 800
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
GSK | $39.685 1.06% 380K
|
Health Technology
|
| O: 0.11%
H: 0.69%
C: -1.23%
LLY | $731.1 -1.99% 1M
|
Health Technology
|
| O: 0.29%
H: 0.27%
C: -3.89%
SNY | News | $46.34 2.09% 620K
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
AZN | $68.545 0.27% 1.2M
|
Health Technology
|
| O: 0.35%
H: 0.86%
C: -0.21%
research market
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
ZCMD | $1.98 36.55% 27M
|
Commercial Services
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
AULT | $0.304 25.57% 47M
|
Manufacturing
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.